Education
About Us
Working with TipRanks
Follow Us
Applied DNA Sciences (BNBX)
NASDAQ:BNBX
BNBX Stock Chart & Stats
$3.17
--
Market closed
$3.17
--
Day’s Range― - ―
52-Week Range$2.13 - $191.27
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.96M
Market Cap
$10.84M
Enterprise Value-$1.72M
Total Cash (Recent Filing)$4.73M
Total Debt (Recent Filing)$334.40K
Price to Earnings (P/E)―
Beta2.65
Next Earnings
Dec 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,354,782
10 Day Avg. Volume46,292
30 Day Avg. Volume1,955,224
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.04
Price to Sales (P/S)0.12
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.16
Enterprise Value/Revenue-0.52
Enterprise Value/Gross Profit-1.32
Enterprise Value/Ebitda0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Applied DNA Sciences News
BNBX FAQ
What was Applied DNA Sciences’s price range in the past 12 months?
Applied DNA Sciences lowest stock price was $2.13 and its highest was $191.27 in the past 12 months.
What is Applied DNA Sciences’s market cap?
Applied DNA Sciences’s market cap is $10.84M.
When is Applied DNA Sciences’s upcoming earnings report date?
Applied DNA Sciences’s upcoming earnings report date is Dec 11, 2025 which is yesterday.
How were Applied DNA Sciences’s earnings last quarter?
Currently, no data Available
Is Applied DNA Sciences overvalued?
According to Wall Street analysts Applied DNA Sciences’s price is currently Overvalued.
Does Applied DNA Sciences pay dividends?
Applied DNA Sciences does not currently pay dividends.
What is Applied DNA Sciences’s EPS estimate?
Applied DNA Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Applied DNA Sciences have?
Applied DNA Sciences has 4,354,782 shares outstanding.
What happened to Applied DNA Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Applied DNA Sciences?
Currently, no hedge funds are holding shares in BNBX
Company Description
Applied DNA Sciences
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Technical Analysis
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
Mainz Biomed B.V.
―
Ownership Overview
4.36% Insiders
0.05% Mutual Funds
<0.01% Other Institutional Investors
95.59% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---